NPAS2 promotes cell survival of hepatocellular carcinoma by transactivating CDC25A

Emerging evidences show that disruption of the circadian rhythm is associated with tumor initiation and progression. Neuronal PAS domain protein 2 (NPAS2), one of the core circadian molecules, has been proved to be a potential prognostic biomarker in colorectal and breast cancers. However, to date,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Peng, Li, Jibin, Zhou, Feng, Huang, Qichao, Zhang, Jiansheng, Guo, Xu, Lyu, Zhuomin, Zhang, Hongxin, Xing, Jinliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386534/
https://www.ncbi.nlm.nih.gov/pubmed/28333141
http://dx.doi.org/10.1038/cddis.2017.131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386534/
https://www.ncbi.nlm.nih.gov/pubmed/28333141
http://dx.doi.org/10.1038/cddis.2017.131

Ejemplares similares